85 results on '"Mohamed Abdo Rizk"'
Search Results
2. Global prevalence and species diversity of tick-borne pathogens in buffaloes worldwide: a systematic review and meta-analysis
- Author
-
El-Sayed El-Alfy, Ibrahim Abbas, Rana Elseadawy, Somaya Saleh, Bassem Elmishmishy, Shimaa Abd El-Salam El-Sayed, and Mohamed Abdo Rizk
- Subjects
Infectious Diseases ,Parasitology - Abstract
Background Buffaloes are important contributors to the livestock economy in many countries, particularly in Asia, and tick-borne pathogens (TBPs) commonly infect buffaloes, giving rise to serious pathologies other than their zoonotic potential. Methods The present investigation focuses on the prevalence of TBPs infecting buffaloes worldwide. All published global data on TBPs in buffaloes were collected from different databases (e.g., PubMed, Scopus, ScienceDirect, and Google Scholar) and subjected to various meta-analyses using OpenMeta[Analyst] software, and all analyses were conducted based on a 95% confidence interval. Results Over 100 articles discussing the prevalence and species diversity of TBPs in buffaloes were retrieved. Most of these reports focused on water buffaloes (Bubalus bubalis), whereas a few reports on TBPs in African buffaloes (Syncerus caffer) had been published. The pooled global prevalence of the apicomplexan parasites Babesia and Theileria, as well as the bacterial pathogens Anaplasma, Coxiella burnetii, Borrelia, Bartonella, and Ehrlichia in addition to Crimean-Congo hemorrhagic fever virus, were all evaluated based on the detection methods and 95% confidence intervals. Interestingly, no Rickettsia spp. were detected in buffaloes with scarce data. TBPs of buffaloes displayed a fairly high species diversity, which underlines the high infection risk to other animals, especially cattle. Babesia bovis, B. bigemina, B. orientalis, B. occultans and B. naoakii, Theileria annulata, T. orientalis complex (orientalis/sergenti/buffeli), T. parva, T. mutans, T. sinensis, T. velifera, T. lestoquardi-like, T. taurotragi, T. sp. (buffalo) and T. ovis, and Anaplasma marginale, A. centrale, A. platys, A. platys-like and “Candidatus Anaplasma boleense” were all were identified from naturally infected buffaloes. Conclusions Several important aspects were highlighted for the status of TBPs, which have serious economic implications for the buffalo as well as cattle industries, particularly in Asian and African countries, which should aid in the development and implementation of prevention and control methods for veterinary care practitioners, and animal owners. Graphical Abstract
- Published
- 2023
3. Effect of methanolic extract from Capsicum annuum against the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice
- Author
-
Mohamed Abdo Rizk, Shimaa Abd El-Salam El-Sayed, Mostafa Al-Araby, and Ikuo Igarashi
- Subjects
in vivo ,theileria ,General Veterinary ,Veterinary medicine ,SF600-1100 ,parasitic diseases ,in vitro ,SF1-1100 ,capsicum annuum ,babesia ,combination therapy ,Animal culture - Abstract
Background and Aim: Piroplasmosis is a serious disease that infects animals, inflicting significant economic losses in the livestock industry and animal trade worldwide. Anti-piroplasm drugs now on the market have demonstrated host toxicity and parasite resistance. As a result, developing more effective and safer anti-piroplasm drugs becomes an urgent issue. This study aimed to evaluate the inhibitory effect of Capsicum annuum methanolic extract (CA) against the growth of Babesia bovis, Babesia divergens, Babesia caballi, and Theileria equi in vitro and against B. microti in mice. Materials and Methods: Fluorescence-based SYBR Green I assay was used to evaluate CA's inhibitory effect in vitro and in vivo when used either as a monotherapy or combined with diminazene aceturate (DA). The hematological parameters (HCT, hemoglobin, and red blood cells counts) were determined in the blood of mice every 96 h using Celltac α MEK-6450 electronic hematology analyzer. Results: The in vitro growth of B. bovis, B. divergens, T. equi, and B. caballi was inhibited by CA in a dose-dependent manner with IC50 values of 4.87±1.23, 44.11±8.03, 8.23±2.54, and 1.26±0.50 mg/mL, respectively. In B. microti-infected mice, a combination therapy consisting of CA and a low dose of DA showed a significant (p
- Published
- 2022
4. Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo
- Author
-
Shengwei Ji, Mingming Liu, Eloiza May Galon, Mohamed Abdo Rizk, Bumduuren Tuvshintulga, Jixu Li, Iqra Zafar, Yae Hasegawa, Aiko Iguchi, Naoaki Yokoyama, and Xuenan Xuan
- Subjects
Mice, Inbred BALB C ,Antiprotozoal Agents ,Short Report ,Naphthoquine phosphate ,Babesia ,Infectious and parasitic diseases ,RC109-216 ,Babesia rodhaini ,Parasitemia ,Inhibitory Concentration 50 ,Mice ,Random Allocation ,Infectious Diseases ,1-Naphthylamine ,Hematocrit ,In vitro ,Babesiosis ,Babesia gibsoni ,parasitic diseases ,In vivo ,Aminoquinolines ,Animals ,Parasitology - Abstract
Background Drug resistance and toxic side effects are major challenges in the treatment of babesiosis. As such, new drugs are needed to combat the emergence of drug resistance in Babesia parasites and to develop alternative treatment strategies. A combination of naphthoquine (NQ) and artemisinin is an antimalarial therapy in pharmaceutical markets. The present study repurposed NQ as a drug for the treatment of babesiosis by evaluating the anti-Babesia activity of naphthoquine phosphate (NQP) alone. Methods An in vitro growth inhibition assay of NQP was tested on Babesia gibsoni cultures using a SYBR Green I-based fluorescence assay. In addition, the in vivo growth inhibitory effect of NQP was evaluated using BALB/c mice infected with Babesia rodhaini. The parasitemia level and hematocrit values were monitored to determine the therapeutic efficacy of NQP and the clinical improvements in NQP-treated mice. Results The half maximal inhibitory concentration of NQP against B. gibsoni in vitro was 3.3 ± 0.5 μM. Oral administration of NQP for 5 consecutive days at a dose of 40 mg/kg of body weight resulted in significant inhibition of B. rodhaini growth in mice as compared with that of the control group. All NQP-treated mice survived, whereas the mice in the control group died between days 6 and 9 post-infection. Conclusion This is the first study to evaluate the anti-Babesia activity of NQP in vitro and in vivo. Our findings suggest that NQP is a promising drug for treating Babesia infections, and drug repurposing may provide new treatment strategies for babesiosis. Graphical Abstract
- Published
- 2022
5. Molecular detection of Babesia microti in one-humped camel (Camelus dromedarius) in Halayeb and Shalateen, Halayeb, Egypt
- Author
-
Mohamed Abdo Rizk
- Subjects
endocrine system ,Phylogenetic tree ,Transmission (medicine) ,animal diseases ,Pcr assay ,BABESIA MICROTI ,Biology ,Ribosomal RNA ,biology.organism_classification ,Virology ,parasitic diseases ,Babesia ,Blood parasites ,Nested polymerase chain reaction - Abstract
There is paucity in the epidemiological screening of a blood parasite of zoonotic importance, Babesia microti (B. microti) in camels in Egypt. Therefore, a total of 142 individuals of one humped camel (Camelus dromedarius) that were bred in Halayeb and Shalateen were examined for infection and subjected to phylogenetic analysis on blood parasite infection with B. microti. PCR assay focusing on the Babesia microti small subunit rRNA (ss-rRNA) gene was used for detection of its prevalence in camels. Phylogenetic analysis revealed the detection of 17 case from a total of 142 cases with an infection rate of 11.97% using nested PCR assays. Moreover, phylogenetic analyses showed that B. microti was genetically related with German strain that is isolated from voles and rats in France. In conclusion, this is the first evidence of B. microti infection in camels in Egypt with evidence of the role of one-humped camels in sustaining the babesia transmission in Egypt.
- Published
- 2021
6. Phenytoin: A promising non-antibiotic drug for the topical treatment of digital dermatitis in dairy cows
- Author
-
El-Sayed El-Shafaey, Eman A. Abo Elfadl, Mohamed A. Hamed, Mohamed Abdo Rizk, and Naglaa A. Gomaa
- Subjects
Drug ,Phenytoin ,medicine.medical_specialty ,General Veterinary ,digital dermatitis ,business.industry ,media_common.quotation_subject ,Veterinary medicine ,Digital dermatitis ,phenytoin ,Topical treatment ,medicine.disease ,Dermatology ,SF1-1100 ,Animal culture ,cows ,SF600-1100 ,medicine ,chlortetracycline ,business ,Non antibiotic ,Research Article ,media_common ,medicine.drug - Abstract
Background and Aim: Digital dermatitis (DD) is one of the most common causes of lameness in dairy cattle. It is seen in nearly all dairy herds across the world and has substantial welfare and economic implications. In this study, we aimed to investigate the efficacy of phenytoin sodium topical treatment on painful ulcerative stage of bovine digital dermatitis (BDD). Materials and Methods: In total, 45 Holstein-Friesian dairy cows with DD were randomly assigned to one of the three topical treatment trials (15 each): Saline solution (first treatment, negative control), chlortetracycline spray (second treatment, positive control), or phenytoin sodium powder (third treatment, positive control) (third treatment). On day 0 (pre-treatment) and on days 7, 14, 21, and 28 post-treatment, the response of DD-affected cows to the medications used was evaluated by measuring lesion depth and size, as well as the total clinical score (lameness, pain, and discomfort). Results: The cure rate in cows treated with phenytoin (86.66%) on day 28 was significantly improved compared to cows treated with either chlortetracycline (60%) or normal saline (6.66 %). Conclusion: Our findings highlight the superiority of phenytoin over the commonly used antibacterial agent, chlortetracycline, in the topical treatment of BDD, and subsequently suggest that phenytoin should be considered a suitable alternative treatment option for the treatment of BDD.
- Published
- 2021
7. The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease
- Author
-
Basma H. Marghani, Mohamed El-Adl, Ahmed I. Ateya, Basma H. Othman, Heba I. Ghamry, Mustafa Shukry, Mohamed Mohamed Soliman, and Mohamed Abdo Rizk
- Subjects
Endocrinology, Diabetes and Metabolism ,cyclosporine A ,chronic kidney disease ,oxidative stress ,UGT1A1 antisense ,mild unconjugated hyperbilirubinemia ,Molecular Biology ,Biochemistry - Abstract
Cyclosporine A (CSA) is an immunosuppressive drug that has improved transplant survival rates. However, its use is often limited because it is thought to be linked to the development of chronic kidney disease after kidney transplants. This study aimed to investigate the protective effects and underlying mechanisms of physiological unconjugated (UC) hyperbilirubinemia mediated by UGT1A1 antisense oligonucleotide in a mouse model of CsA-induced chronic kidney disease, and match these with that of chitosan (CH) as a natural chelator against kidney injury. In the current study, CsA-treated mice were given an intravenous injection of UGT1A1 antisense morpholino oligonucleotide (16 µg/kg) every third day for 14 days. In serum samples, bilirubin, creatinine, and urea were determined. Markers of oxidative stress, antioxidant activities, and mRNA expression of target genes PPAR-α, cFn, eNOS, NF-B, AT1-R, ETA-R, Kim-1, and NGAL were measured in the kidney tissues. Moreover, histopathological examinations were carried out on the kidney tissue. Physiological UC hyperbilirubinemia could be a promising protective strategy against CsA-induced kidney disease in transplant recipients. UGT1A1 antisense oligonucleotide-induced physiological UC hyperbilirubinemia serum significantly protected against CsA-induced kidney dysfunction. UCB acts as a signaling molecule that protects against kidney disease through different mechanisms, including antioxidant, anti-inflammatory, and hormonal action, by activating nuclear hormone receptors (PPAR-α). Moreover, it significantly downregulated mRNA expression of NF-kB, ETA-R, iNOS, AT1-R, cFn, Kim-1, and NGAL in the kidney tissue and alleviated CsA-induced kidney histological changes in CsA-treated mice.
- Published
- 2022
- Full Text
- View/download PDF
8. Efficacy of the Antimalarial MMV390048 against Babesia Infection Reveals Phosphatidylinositol 4-Kinase as a Druggable Target for Babesiosis
- Author
-
Shengwei Ji, Eloiza May Galon, Mohamed Abdo Rizk, Yunpeng Yi, Iqra Zafar, Hang Li, Zhuowei Ma, Aiko Iguchi, Masahito Asada, Mingming Liu, and Xuenan Xuan
- Subjects
Pharmacology ,Aminopyridines ,Babesia ,Mice, SCID ,Parasitemia ,Antimalarials ,Mice ,Infectious Diseases ,Babesiosis ,Animals ,Pharmacology (medical) ,Experimental Therapeutics ,Sulfones ,1-Phosphatidylinositol 4-Kinase - Abstract
The present study aimed to evaluate the anti-Babesia effect of MMV390048, a drug that inhibits Plasmodium by targeting the phosphatidylinositol 4-kinase (PI4K). The half inhibitory concentration (IC(50)) of MMV390048 against the in vitro growth of Babesia gibsoni was 6.9 ± 0.9 μM. In immunocompetent mice, oral treatment with MMV390048 at a concentration of 20 mg/kg effectively inhibited the growth of B. microti (Peabody mjr strain). The peak parasitemia in the control group was 30.5%, whereas the peak parasitemia in the MMV390048-treated group was 3.4%. Meanwhile, MMV390048 also showed inhibition on the growth of B. rodhaini (Australia strain), a highly pathogenic rodent Babesia species. All MMV390048-treated mice survived, whereas the mice in control group died within 10 days postinfection (DPI). The first 7-day administration of MMV390048 in B. microti-infected, severe combined immunodeficiency (SCID) mice delayed the rise of parasitemia by 26 days. Subsequently, a second 7-day administration was given upon recurrence. At 52 DPI, a parasite relapse (in 1 out of 5 mice) and a mutation in the B. microti PI4K L746S, a MMV390048 resistance-related gene, were detected. Although the radical cure of B. microti infection in immunocompromised host SCID mice was not achieved, results from this study showed that MMV390048 has excellent inhibitory effects on Babesia parasites, revealing a new treatment strategy for babesiosis: targeting the B. microti PI4K.
- Published
- 2022
9. Molecular detection and identification of Babesia bovis and Trypanosoma spp. in one-humped camel (Camelus dromedarius) breeds in Egypt
- Author
-
Mohamed El-Adl, Magdy Elgioushy, Mostafa AbdElsalam Alaraby, Shimaa Abd El-Salam El-Sayed, Shimaa Sobhy Sorour, Mosaab A. Omar, Mohamed El-Beskawy, Mayar Ali, and Mohamed Abdo Rizk
- Subjects
Veterinary medicine ,endocrine system ,camel ,Population ,trypanosoma spp ,SF1-1100 ,030308 mycology & parasitology ,law.invention ,03 medical and health sciences ,law ,SF600-1100 ,Internal transcribed spacer ,education ,egypt ,Polymerase chain reaction ,030304 developmental biology ,0303 health sciences ,education.field_of_study ,General Veterinary ,biology ,Babesia bovis ,Trypanosoma evansi ,biology.organism_classification ,Animal culture ,babesia bovis ,Babesia ,Trypanosoma ,epidemiology ,Nested polymerase chain reaction ,Research Article - Abstract
Background and Aim: Camels are a unique source of milk and meat, which helps recover from several diseases that affect humans worldwide. In Egypt, one of the great obstacles for this industry is tick-borne diseases. This study aimed to characterize blood parasite infections, such as Babesia (B.) bovis and Trypanosoma (T.) spp. in one-humped camel (Camelus dromedarius) (n=142) breeds in Halayeb and Shalateen, Egypt, through phylogenetic analysis. Materials and Methods: The prevalence of B. bovis and Trypanosoma spp. was identified in camels using polymerase chain reaction (PCR) assays targeting the Rhoptry-Associated Protein-1 and internal transcribed spacer 1 genes, respectively. A nested PCR technique was conducted to detect B. bovis. At the same time, KIN multispecies PCR assay was employed to diagnose and classify trypanosome DNA in camels. Results: B. bovis was detected in 4/142 camels with an infection rate of 2.81%. Sequencing and phylogenetic analyses revealed that the strain of B. bovis isolated from this population was closely related to strains isolated from Argentine, the United States, and Brazil. Moreover, Trypanosoma evansi was detected in 8/142 camels with an infection rate of 5.63%. Sequencing and phylogenetic analyses revealed that this isolated strain T. evansi was closely related to Trypanosoma theileri detected from cattle in Brazil. Conclusion: The obtained data indicated the existence of B. bovis and T. evansi in camels from two provinces of Egypt. The obtained findings have economic significance and reflect the importance of implementing effective prevention and control methods across Egypt to reduce the incidence of B. bovis and T. evansi in camels.
- Published
- 2021
10. Phylogenetic study of Theileria ovis and Theileria lestoquardi in sheep from Egypt: Molecular evidence and genetic characterization
- Author
-
Suresh Mickymaray, Anand Paramasivam, Ahmed Elkhtam, Amira A. T. Al-Hosary, Manal Mohammed Hawash, Ahmed Elsify, Mohammad Ali Al-Wabel, Mohamed Nayel, Mosaab A. Omar, Abdulaziz M. Almuzaini, Mohamed Abdo Rizk, Layla Omran Elmajdoub, Akram Salama, and Laila S. Ahmed
- Subjects
Veterinary medicine ,polymerase chain reaction ,030231 tropical medicine ,Theileria ovis ,Biology ,phylogeny ,SF1-1100 ,18S ribosomal RNA ,030308 mycology & parasitology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Phylogenetics ,Theileria ,SF600-1100 ,egypt ,Ovis ,theileria ovis ,Polymerase chain reaction ,0303 health sciences ,General Veterinary ,Phylogenetic tree ,biology.organism_classification ,Breed ,Animal culture ,Research Article ,theileria lestoquardi - Abstract
Background and Aim: Ovine theileriosis caused by Theileria ovis and Theileria lestoquardi is an important infectious disease affecting small ruminants in regions of the tropic and subtropic zones. There is limited studies about ovine theileriosis in Egypt; so the present study aims to assess the occurrence of ovine theileriosis in Egypt at the molecular level. Materials and Methods: Blood samples were collected from 115 randomly selected sheep, which were apparently healthy; the ages of the sampled sheep ranged from 1 to 5 years old, from a local breed (barkae and balade), and showed no symptoms indicating infection with Theileria spp. The study was conducted in three governorates representing Lower Egypt (Menoufia and Beheira) and Upper Egypt (El-Wady El-Geded). All blood samples were subjected to polymerase chain reaction (PCR) and semi-nested PCR to target Theileria spp. 18S rRNA genes. Positive samples were sequenced, and these sequences were analyzed using nucleotide basic local alignment search tool (BLAST). Results: Six animals (5.22%) were PCR-positive carriers for ovine theileriosis. Nucleotide BLAST and phylogenetic analyses of the six obtained sequences showed that T. ovis was present in five animals (4.37%) in Menoufia (n=2) and El-Wady El-Geded (n=3), whereas T. lestoquardi was detected in 1 animal (0.87%) in El-Wady El-Geded. Conclusion: This study is the first to provide molecular evidence, genetic characterization, and phylogenetic analysis of ovine Theileria spp. in Egypt. Specifically, T. lestoquardi and T. ovis carrier statuses of sheep were confirmed. These results highlight the importance of developing an effective control strategy against ovine theileriosis carriers that might develop and/or spread theileriosis.
- Published
- 2021
11. Development of a promising antigenic cocktail for the global detection of Babesia caballi in horse by ELISA
- Author
-
Shimaa Abd El-Salam El-Sayed, Mohamed Abdo Rizk, Hanadi B. Baghdadi, Aaron Edmond Ringo, Gantuya Sambuu, Arifin Budiman Nugraha, and Ikuo Igarashi
- Subjects
Multidisciplinary - Abstract
In this study, we designed novel truncated Babesia caballi (B. caballi) recombinant proteins from the previously used B. caballi proteins; 134-Kilodalton Protein (rBC134) and Merozoite Rhoptry 48 Protein (rBC48). Then, we evaluated the diagnostic performance of the newly designed proteins when used as a single antigen or when used as cocktail antigen consists of rBC134 full length (rBC134f) + newly designed rBC48 (rBC48t) or newly designed rBC134 (rBC134t) + rBC48t for the detection of B. caballi infection in horse using indirect enzyme-linked immunosorbent assay (iELISA). We used one dose and a half of each antigen in the cocktail formulas. The serum samples were collected from different endemic areas in addition to the sera collected from horses experimentally infected with B. caballi were used in the present study. Cocktail antigen in full dose of (rBC134f + rBC48t) exhibited the highest optical density (OD) values with B. caballi–infected sera and showed the lowest OD values with normal equine sera or B. caballi, and Theileria equi mixed infected sera in comparison with the single antigen. Interestingly, the same cocktail antigen exhibited the highest concordance rate (76.74%) and kappa value (0.79) in the screening of 200 field serum samples collected from five B. caballi endemic countries, including South Africa (n = 40), Ghana (n = 40), Mongolia (n = 40), Thailand (n = 40), and China (n = 40) using iELISA and the results were compared to those of indirect fluorescent antibody test (IFAT) as a reference. Moreover, the identified promising cocktail full dose antigen (rBC134f + rBC48t) showed that it can detect the infection as early as the 4th day post-infection in sera collected from experimentally infected horses. The obtained results revealed the reliability of the rBC134f + rBC48t cocktail antigen when used in full dose for the detection of specific antibodies to B. caballi in horses which will be useful for epidemiological surveys and control of equine babesiosis.
- Published
- 2023
12. Pomegranate (
- Author
-
Rasha, Eltaysh, Mohamed Abdo, Rizk, Bassem, Elmishmishy, Shimaa Abd El-Salam, El-Sayed, Khaled, Abouelnasr, and Ikuo, Igarashi
- Abstract
Pomegranate (
- Published
- 2022
13. Ascorbic acid co-administration with a low dose of diminazene aceturate inhibits the in vitro growth of Theileria equi, and the in vivo growth of Babesia microti
- Author
-
Mohamed Abdo Rizk, Shimaa Abd El-Salam El-Sayed, and Ikuo Igarashi
- Subjects
Babesia ,Ascorbic Acid ,Babesia microti ,Theileriasis ,Mice ,Infectious Diseases ,Babesiosis ,Theileria ,Animals ,Parasitology ,Cattle ,Horse Diseases ,Horses ,Diminazene - Abstract
In the current investigation, the effect of ascorbic acid on the in vitro growth of several piroplasm including Babesia bovis (Bartonella bovis), Baconia bigemina, B. caballi, and Theileria equi (T. equi), as well as against Brucella microti in mice was assessed. The antipiroplasm efficacy of ascorbic acid in vitro and in vivo was assessed using a fluorescence-based SYBR Green I test. Using atom pair fingerprint (APfp), we investigated the structural similarity between ascorbic acid and the commonly used antibabesial medicines, diminazene aceturate (DA) and imidocarb dipropionate (ID). In vitro cultures of B. bovis and T. equi were utilized to determine the ascorbic acid and DA interaction using the Chou-Talalay method. Ascorbic acid inhibited B. bovis, B. bigemina, T. equi, and B. caballi growth in vitro in a dose-dependent manner. The APfp results revealed that ascorbic acid and DA have a maximum structural similarity (MSS). On a T. equi culture in vitro, ascorbic acid showed a synergistic interaction with DA, with a combination index of 0.28. B. microti growth was decreased by 41% in vivo using ascorbic acid combined with a very low dosage of DA (6.25 mg kg
- Published
- 2022
14. Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis
- Author
-
Mohamed Abdo Rizk, Hanadi B. Baghdadi, Shimaa Abd El-Salam El-Sayed, Rasha Eltaysh, and Ikuo Igarashi
- Subjects
Imidocarb ,Mice ,Infectious Diseases ,Cysteine Proteases ,Babesiosis ,Theileria ,Drug Repositioning ,Animals ,Parasitology ,Babesia microti ,Clofazimine ,Atovaquone ,Malaria - Abstract
Background An innovative approach has been introduced for identifying and developing novel potent and safe anti-Babesia and anti-Theileria agents for the control of animal piroplasmosis. In the present study, we evaluated the inhibitory effects of Malaria Box (MBox) compounds (n = 8) against the growth of Babesia microti in mice and conducted bioinformatics analysis between the selected hits and the currently used antibabesial drugs, with far-reaching implications for potent combinations. Methods A fluorescence assay was used to evaluate the in vivo inhibitory effects of the selected compounds. Bioinformatics analysis was conducted using hierarchical clustering, distance matrix and molecular weight correlation, and PubChem fingerprint. The compounds with in vivo potential efficacy were selected to search for their target in the piroplasm parasites using quantitative PCR (qPCR). Results Screening the MBox against the in vivo growth of the B. microti parasite enabled the discovery of potent new antipiroplasm drugs, including MMV396693 and MMV665875. Interestingly, statistically significant (P Theileria equi in vitro culture in comparison with untreated cultures. MMV396693/clofazimine and MMV665875/atovaquone (AV) showed maximum structural similarity (MSS) with each other. The distance matrix results indicate promising antibabesial efficacy of combination therapies consisting of either MMV665875 and AV or MMV396693 and imidocarb dipropionate (ID). Conclusions Inhibitory and hematology assay results suggest that MMV396693 and MMV665875 are potent antipiroplasm monotherapies. The structural similarity results indicate that MMV665875 and MMV396693 have a similar mode of action as AV and ID, respectively. Our findings demonstrated that MBox compounds provide a promising lead for the development of new antibabesial therapeutic alternatives. Graphical Abstract
- Published
- 2022
15. Evaluation of the
- Author
-
Rasha, Eltaysh, Mohamed Abdo, Rizk, Shimaa Abd El-Salam, El-Sayed, Khaled, Abouelnasr, Abdelnaser Ahmed, Abdallah, and Ikuo, Igarashi
- Abstract
The effect ofFluorescence assay using SYBR Green I stain was used to evaluate the antibabesial efficacy inhibitory ofThese data show that
- Published
- 2022
16. Molecular Detection and Assessment of Risk Factors for Tick-Borne Diseases in Sheep and Goats from Turkey
- Author
-
Mohamed Abdo Rizk, Aaron Edmond Ringo, Onur Ceylan, Yongchang Li, Byamukama Benedicto, Ferda Sevinc, Paul Frank Adjou Moumouni, Shengwei Ji, Jixu Li, Maria Agnes Tumwebaze, Mingming Liu, Seung-Hun Lee, Eloiza May Galon, and Xuenan Xuan
- Subjects
Male ,Anaplasmosis ,Veterinary medicine ,Anaplasma ,Turkey ,Babesia ,Sheep Diseases ,Risk Factors ,Babesiosis ,Theileria ,parasitic diseases ,medicine ,Animals ,Ovis ,Tick-borne disease ,Goat Diseases ,Sheep ,biology ,Goats ,Anaplasma ovis ,biology.organism_classification ,medicine.disease ,Anaplasma phagocytophilum ,Theileriasis ,Parasitology ,Tick-Borne Diseases ,Female - Abstract
Tick-borne diseases mainly, theileriosis, babesiosis and anaplasmosis cause significant economic losses in livestock globally, including Turkey. The tick-borne pathogens of small ruminants in Turkey have been studied widely but information on molecular characterization and disease occurrence is still limited. In this study, both microscopy and molecular detection and characterization for Theileria spp. Babesia ovis, Anaplasma ovis and Anaplasma phagocytophilum was conducted. A total of 133 blood samples of tick-infested small ruminants (105 sheep and 28 goats) were collected from Turkey: half of the animals had clinical signs of tick-borne disease infections. Using PCR assays and microscopy, 90.2% and 45.1% of the samples were positive for at least one pathogen, respectively. Overall, the infection rates of A. phagocytophilum, B. ovis, A. ovis, Theileria spp. were 66.7%, 62.4%, 46.6% and 7.0%, respectively. Fifty-nine of the 133 (44.4%) samples were co-infected with two or more pathogens. Sex, season and B. ovis positivity were significant risk factors for occurrence of clinical disease. Sequence and phylogenetic analysis based on B. ovis 18S small subunit rRNA, A. ovis major surface protein 4, Theileria spp. 18S rRNA and A. phagocytophilum 16S rRNA genes showed that the isolates in this study clustered together in well-supported clades with those previously collected from Turkey and other countries. The study shows B. ovis as the most significant pathogen associated with clinical and fatal cases in small ruminants from Turkey. Female sex and summer season are associated with increased risk of the disease. This study shows high infection rates with the pathogens among small ruminants including A. phagocytophilum which has veterinary and public health importance.
- Published
- 2020
17. Identification and Characterization of P0 Protein as a Vaccine Candidate Against Babesia divergens, Blood Parasite of Veterinary and Zoonotic Importance
- Author
-
Shimaa Abd El-Salam El-Sayed, Mohamed Abdo Rizk, Haitham Eldoumani, Shimaa Sobhy Sorour, Mohamad Alaa Terkawi, Mahmoud AbouLaila, Ikuo Igarashi, and Mohamed Z. Sayed-Ahmed
- Subjects
Babesia divergens ,P0 protein ,General Veterinary ,diagnosis ,Veterinary medicine ,vaccine ,SF600-1100 ,Veterinary Science ,zoonotic infection ,Original Research - Abstract
The molecular identification and antigenic characterization of P0 protein in Babesia divergens, a blood parasite of veterinary and zoonotic importance, were carried out in this study for use in developing subunit vaccines against B. divergens infection. Recombinant protein encoding P0 (BdP0) was developed in Escherichia coli, and its antiserum was generated in mice for further molecular characterization. Anti-rBdP0 serum had a specific interaction with the corresponding legitimate B. divergens protein, as confirmed by Western blotting and indirect fluorescent antibody tests. ELISA was used to assess the immunogenicity of BdP0 in a group of 68 bovine field samples, and significant immunological reactivity was found in 19 and 20 positive samples of rBdp0 and B. divergens lysate, respectively. The in vitro growth of B. divergens cultures treated with anti-rBdP0 serum was significantly inhibited (p < 0.05). Furthermore, after 6 h of incubation with 2 mg/ml anti-rBdP0 serum, the ability of pre-incubated free merozoites to invade bovine erythrocytes was reduced by 59.88%. The obtained data suggest the possible use of rBdP0 as diagnostic antigen and may serve as a vaccine candidate against babesiosis caused by B. divergens either in animal or human.
- Published
- 2022
18. Pomegranate (Punica granatum) Peel Inhibits the In Vitro and In Vivo Growth of Piroplasm Parasites
- Author
-
Rasha Eltaysh, Mohamed Abdo Rizk, Bassem Elmishmishy, Shimaa Abd El-Salam El-Sayed, Khaled Abouelnasr, and Ikuo Igarashi
- Subjects
Infectious Diseases ,Article Subject ,Parasitology - Abstract
Pomegranate (Punica granatum) peel has seen a rapid surge in attention as a medical and nutritional product over the last decade. The impact of pomegranate peel methanolic extract monotherapy and combination therapy on the in vitro growth of Babesia (B.) bovis, B. bigemina, B. divergens, B. caballi, and Theileria (T.) equi, as well as B. microti in mice, was investigated in this work. Fluorescence-based SYBR green I assay was used for evaluating the inhibitory antibabesial efficacy of pomegranate (Punica granatum) peel against the growth of several piroplasm parasites in vitro and in vivo. Celltac α MEK-6450 computerized haematology analyzer was used for monitoring the haematological parameters of treated mice every 4 days. Pomegranate peel inhibited the in vitro growth of B. bovis, B. bigemina, B. divergens, T. equi, and B. caballi in a dose-dependent manner, with IC50 values of 154.45 ± 23.11 , 40.90 ± 9.35 , 72.71 ± 14.77 , 100 ± 16.20 , and 77.27 ± 16.94 μ g / ml , respectively. On a B. bovis culture, the in vitro inhibitory effect of pomegranate peel was amplified when it was combined with diminazene aceturate (DA). Combination therapy of pomegranate peel and a low dose of DA (15 mg kg-1) inhibited B. microti growth significantly ( P < 0.05 ) higher than the treatment with the full dose of DA (25 mg kg-1) in B. microti-infected mice. These findings suggest that pomegranate peel might be a potential medicinal plant for babesiosis treatment, especially when combined with a low dosage of DA.
- Published
- 2022
- Full Text
- View/download PDF
19. Gastrointestinal Parasites of Dogs in Egypt: An Update on the Prevalence in Dakahlia Governorate and a Meta-Analysis for the Published Data from the Country
- Author
-
Ibrahim Abbas, Hanadi B. Baghdadi, Mohamed Abdo Rizk, El-Sayed El-Alfy, Bassem Elmishmishy, and Mayada Gwida
- Subjects
meta-analysis ,dogs ,General Veterinary ,Toxocara canis ,Egypt ,Animal Science and Zoology ,gastrointestinal parasites ,zoonoses - Abstract
Since the last survey on gastrointestinal (GIT) parasites infecting dogs in Dakahlia governorate, Egypt, was published 40 years ago, the present study detected various GIT parasites in feces of 78 stray dogs in this governorate. Twenty-one dogs (35.9%) had eggs/oocysts of eight different parasites including Toxocara canis (19.2%), Toxascaris leonina (2.6%), hookworms (1.3%), Taenia species (5.1%), Dipylidium caninum (2.6%), Cystoisospora canis (5.1%), Cystoisospora ohioensis (2.6%), and Neospora caninum-like oocysts (1.3%). These results were combined in various meta-analyses with findings of all published surveys on GIT parasites of dogs in Egypt to underline the potential parasitic zoonoses from dogs in the country. Feces and/or gastrointestinal tracts of 19,807 dogs from various Egyptian governorates, but particularly Cairo, have been microscopically tested in 182 datasets published between 1938 and 2022, revealed during our systematic database search. Toxocara canis, interestingly, displayed a twofold higher pooled prevalence (24.7%) when compared to the published global pooled prevalence for T. canis, indicating that dogs represent a major risk for toxocariasis in humans from Egypt. Dipylidium caninum (25.4%) as well as various Taenia species (17.1%) also displayed high pooled prevalences. On the contrary, lower pooled prevalence was estimated for the most important zoonotic taeniid “Echinococcus granulosus” (2.4%) as well as for hookworms (1.8%) in comparison to what has been published from other countries in the region. Relatively high prevalences were estimated for three protozoa detected in dogs and are common to infect children in Egypt; Cryptosporidium (5.5%), Giardia (7.4%), and Entamoeba histolytica (9.8%). In general, the pooled prevalence estimated for various parasites detected in dogs from Egypt has decreased in the recent years, sometimes by as much as one-fifth, but this great decline is statistically insignificant, which should alert the veterinary and public health authorities to continue their efforts for controlling these parasites in a “One Health” approach.
- Published
- 2023
20. Effect of Racing on Blood Gases Components and Selected Biochemical Variables in Racing Camels (Camelus dromedarius)
- Author
-
Mohamed Abdo Rizk, Mohamed El-Adl, Magdy Elgioushy, and Enas A. Noseer
- Subjects
General Veterinary ,Animal Science and Zoology - Published
- 2019
21. Immunomodulatory Effect of Vitamin C on Proinflammatory Cytokines Production in Ossimi Lambs (Ovis aries) with Pneumonic Pasteurellosis
- Author
-
Doaa Salman, Shimaa Abd El-Salam El-Sayed, Basma H. Marghani, Hossam Elshahat Gadalla, Mohamed Abdo Rizk, and Mohamed Z. Sayed-Ahmed
- Subjects
Combination therapy ,Veterinary medicine ,vitamin C ,lambs ,Proinflammatory cytokine ,SF600-1100 ,medicine ,Interferon gamma ,Interleukin 6 ,Ovis ,General Veterinary ,Vitamin C ,biology ,pneumonic pasteurellosis ,business.industry ,biology.organism_classification ,cytokines ,Pneumonic pasteurellosis ,QL1-991 ,Immunology ,biology.protein ,Egypt ,Animal Science and Zoology ,Tumor necrosis factor alpha ,business ,Zoology ,medicine.drug - Abstract
In this study, we have investigated the impact of vitamin C on the production of pro-inflammatory cytokines (interleukin 1 β (IL-1 β), interleukin 6 (IL-6), interleukin 12p40 (IL-12p40), interferon gamma (IFNγ), and tumor necrosis factor alpha (TNF-α)) in lambs naturally infected by pneumonic pasteurellosis. Of 37 lambs, 18 lambs were identified to have pneumonic pasteurellosis and randomly allocated into two equal groups. Single subcutaneous dose of tulathromycine alone (2.5 mg kg−1) or tulathromycine combined with vitamin C (3 gm kg−1) were administrated to the diseased lambs. The serum levels of IL-1β, IL-6, IFN-γ, and TNF-α were returned to the normal levels in pneumonic lambs treated with the combination therapy. The obtained results indicate the selective influences of vitamin C on pro-inflammatory cytokines production in sera of lambs with pneumonic pasteurellosis and highlights the value of vitamin C as a potential anti-inflammatory drug and ideal immunomodulatory agent.
- Published
- 2021
- Full Text
- View/download PDF
22. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of Babesia divergens, a Blood-Borne Parasite of Veterinary and Zoonotic Importance
- Author
-
Ikuo Igarashi, Mohamed Abdo Rizk, Khalaf F. Alsharif, Shimaa Abd El-Salam El-Sayed, Mohamed M. Abdel-Daim, and Mahmoud S. Alkhoudary
- Subjects
Veterinary medicine ,Pharmaceutical Science ,Analytical Chemistry ,QD241-441 ,malaria box ,Drug Discovery ,medicine ,Parasite hosting ,Physical and Theoretical Chemistry ,Babesia divergens ,IC50 ,large-scale screening ,biology ,Organic Chemistry ,in vitro ,Babesiosis ,biology.organism_classification ,medicine.disease ,In vitro ,MMV006913 ,Chemistry (miscellaneous) ,Infectious disease (medical specialty) ,Molecular Medicine ,Malaria ,Atovaquone ,medicine.drug - Abstract
Babesiosis is an infectious disease with an empty drug pipeline. A search inside chemical libraries for novel potent antibabesial candidates may help fill such an empty drug pipeline. A total of 400 compounds (200 drug-like and 200 probe-like) from the Malaria Box were evaluated in the current study against the in vitro growth of Babesia divergens (B. divergens), a parasite of veterinary and zoonotic importance. Novel and more effective anti-B. divergens drugs than the traditionally used ones were identified. Seven compounds (four drug-like and three probe-like) revealed a highly inhibitory effect against the in vitro growth of B. divergens, with IC50s ≤ 10 nanomolar. Among these hits, MMV006913 exhibited an IC50 value of 1 nM IC50 and the highest selectivity index of 32,000. The atom pair fingerprint (APfp) analysis revealed that MMV006913 and MMV019124 showed maximum structural similarity (MSS) with atovaquone and diminazene aceturate (DA), and with DA and imidocarb dipropionate (ID), respectively. MMV665807 and MMV665850 showed MMS with each other and with ID. Of note, a high concentration (0.75 IC50) of MMV006913 caused additive inhibition of B. divergens growth when combined with DA at 0.75 or 0.50 IC50. The Medicines for Malaria Venture box is a treasure trove of anti-B. divergens candidates according to the obtained results.
- Published
- 2021
- Full Text
- View/download PDF
23. Discovering the Potent Inhibitors Against Babesia bovis in vitro and Babesia microti in vivo by Repurposing the Natural Product Compounds
- Author
-
Ikuo Igarashi, Mohamed Abdo Rizk, Byamukama Benedicto, Bayin Chahan, Yongchang Li, Naoaki Yokoyama, Aaron Edmond Ringo, Mingming Liu, Xuenan Xuan, Shengwei Ji, Eloiza May Galon, Iqra Zafar, Jixu Li, and Maria Agnes Tumwebaze
- Subjects
General Veterinary ,biology ,Veterinary medicine ,Babesia bovis ,in vitro ,biology.organism_classification ,Babesia microti ,Molecular biology ,In vitro ,chemistry.chemical_compound ,in vivo ,chemistry ,In vivo ,Babesia ,natural product compounds ,SF600-1100 ,Veterinary Science ,Cytotoxicity ,Rottlerin ,IC50 ,Lasalocid ,Original Research - Abstract
In the present study, we screened 502 natural product compounds against the in vitro growth of Babesia (B.) bovis. Then, the novel and potent identified compounds were further evaluated for their in vitro efficacies using viability and cytotoxicity assays. The in vivo inhibitory effects of the selected compounds were evaluated using B. microti “rodent strain” in mice model. Three potent compounds, namely, Rottlerin (RL), Narasin (NR), Lasalocid acid (LA), exhibited the lowest IC50 (half-maximal inhibitory concentration) as follows: 5.45 ± 1.20 μM for RL, 1.86 ± 0.66 μM for NR, and 3.56 ± 1.41 μM for LA. The viability result revealed the ability of RL and LA to prevent the regrowth of treated parasite at 4 × IC50 and 2 × IC50, respectively, while 4 × IC50 of NR was sufficient to stop the regrowth of parasite. The hematology parameters of B. microti in vivo were different in the NR-treated groups as compared to the infected/untreated group. Interestingly, intraperitoneal administration of NR exhibiting inhibition in the growth of B. microti in mice was similar to that observed after administration of the commonly used antibabesial drug, diminazene aceturate (DA) (76.57% for DA, 74.73% for NR). Our findings indicate the richness of natural product compounds by novel potent antibabesial candidates, and the identified potent compounds, especially NR, might be used for the treatment of animal babesiosis.
- Published
- 2021
24. Molecular Investigation of Tick-Borne Haemoparasites Isolated from Indigenous Zebu Cattle in the Tanga Region, Tanzania
- Author
-
Aaron Edmond Ringo, Hezron Emanuel Nonga, Eloiza May Galon, Shengwei Ji, Mohamed Abdo Rizk, Shimaa Abd El-Salam El-Sayed, Uday Kumar Mohanta, Zhuowei Ma, Boniface Chikufenji, Thanh Thom Do, and Xuenan Xuan
- Subjects
General Veterinary ,TBDs ,indigenous zebu cattle ,Tanga ,Tanzania ,pastoral communities ,PCR ,Animal Science and Zoology - Abstract
Tick-borne diseases (TBDs) are a major hindrance to livestock production in pastoral communities of Africa. Although information on tick-borne infections is necessary for setting up control measures, this information is limited in the pastoral communities of Tanzania. Therefore, this study aimed to provide an overview of the tick-borne infections in the indigenous cattle of Tanzania. A total of 250 blood samples were collected from the indigenous zebu cattle in the Tanga region, Tanzania. Then, we conducted a molecular survey using the polymerase chain reaction (PCR) and gene sequencing to detect and identify the selected tick-borne pathogens. The PCR was conducted using assays, based on Theileria spp. (18S rRNA), Theileria parva (p104), Theileria mutans and T. taurotragi (V4 region of the 18S rRNA), Babesia bigemina (RAP-1a), B. bovis (SBP-2), Anaplasma marginale (heat shock protein groEL) and Ehrlichia ruminantium (pCS20). The PCR screening revealed an overall infection rate of (120/250, 48%) for T. mutans, (64/250, 25.6%) for T. parva, (52/250, 20.8%) for T. taurotragi, (33/250, 13.2%) for B. bigemina and (81/250, 32.4%) for A. marginale. Co-infections of up to four pathogens were revealed in 44.8% of the cattle samples. A sequence analysis indicated that T. parvap104 and A. marginalegroEL genes were conserved among the sampled animals with sequence identity values of 98.92–100% and 99.88–100%, respectively. Moreover, the B. bigeminaRAP-1a gene and the V4 region of the 18S rRNA of T. mutans genes were diverse among the sampled cattle, indicating the sequence identity values of 99.27–100% and 22.45–60.77%, respectively. The phylogenetic analyses revealed that the T. parva (p104) and A. marginale (groEL) gene sequences of this study were clustered in the same clade. In contrast, the B. bigemina (RAP-1a) and the T. mutans V4 region of the 18S rRNA gene sequences appeared in the different clades. This study provides important basement data for understanding the epidemiology of tick-borne diseases and will serve as a scientific basis for planning future control strategies in the study area.
- Published
- 2022
25. Inhibitory effect of naphthoquine phosphate against Babesia gibsoni in vitro and Babesia rodhaini in vivo
- Author
-
Yae Hasegawa, Bumduuren Tuvshintulga, Iqra Zafar, Mohamed Abdo Rizk, Shengwei Ji, Jixu Li, Eloiza May Galon, Mingming Liu, Naoaki Yokoyama, and Xuenan Xuan
- Subjects
chemistry.chemical_compound ,Babesia rodhaini ,Chemistry ,Babesia gibsoni ,In vivo ,NAPHTHOQUINE ,Phosphate ,Inhibitory effect ,In vitro ,Microbiology - Abstract
Background: Drug resistance and severe side effects are major challenges in the treatment of babesiosis as they lead to less choices for treatment. Development of new drugs to enrich the treatment strategies and delay the emergence of drug resistance in parasites is still needed. Naphthoquine (NQ) combined with artemisinin treats Plasmodium infection by rapid parasite clearance. The current study repurposed NQ as a babesiosis drug treatment by evaluating the effects of naphthoquine phosphate (NQP) as a single dose treatment for babesiosis. Methods: In vitro anti-Babesia activity of NQP was tested on Babesia gibsoni cultures. The inhibition of parasite growth was verified using a SYBR green I-based fluorescence assay. In vivo efficacy of NQP was evaluated using BALB/c mice infected with Babesia rodhaini. The parasitemia level and hematocrit values were monitored. Results: The half maximal inhibitory concentration of NQP against B. gibsoni in vitro was 3.3 ± 0.5 μM. Oral administration of NQP for 5 successive days at a dose of 40 mg/kg of body weight resulted in significant inhibition on parasite growth compared with the control group. All mice in NQP-treated group survived, whereas the mice in control group died between days 6 and 9 post infection. Conclusion: This is the first study to evaluate the anti-Babesia activity of NQP in vitro and in vivo. The results showed that NQP is a promising drug for babesiosis treatment and drug repurposing may provide new treatment strategies for babesiosis.
- Published
- 2021
26. Immunomodulatory Effect of Vitamin C on Proinflammatory Cytokines Production in Ossimi Lambs (
- Author
-
Mohamed Abdo, Rizk, Shimaa Abd El-Salam, El-Sayed, Doaa, Salman, Basma H, Marghani, Hossam Elshahat, Gadalla, and Mohamed Z, Sayed-Ahmed
- Subjects
pneumonic pasteurellosis ,vitamin C ,Egypt ,lambs ,Article ,cytokines - Abstract
Simple Summary There is paucity on the immunomodulatory and anti-inflammatory effects of vitamin C on cytokines production in lambs with respiratory diseases. Therefore, the current study examined the influence of vitamin C on the production of different pro-inflammatory cytokines in lambs naturally infected by pneumonic pasteurellosis. In lambs naturally infected with pneumonic pasteurellosis, the association between measured proinflammatory cytokines and clinical sum score demonstrated a positive correlation with interleukin-6 and interferon gamma. The findings show that vitamin C has a selective effect on the production of pro-inflammatory cytokines in sera of lambs with pneumonic pasteurellosis when used in combination with tulathromycin, and confirming the therapeutic effectiveness of tulathromycin in clinical recovery of lambs with pneumonic pasteurellosis. Abstract In this study, we have investigated the impact of vitamin C on the production of pro-inflammatory cytokines (interleukin 1 β (IL-1 β), interleukin 6 (IL-6), interleukin 12p40 (IL-12p40), interferon gamma (IFNγ), and tumor necrosis factor alpha (TNF-α)) in lambs naturally infected by pneumonic pasteurellosis. Of 37 lambs, 18 lambs were identified to have pneumonic pasteurellosis and randomly allocated into two equal groups. Single subcutaneous dose of tulathromycine alone (2.5 mg kg−1) or tulathromycine combined with vitamin C (3 gm kg−1) were administrated to the diseased lambs. The serum levels of IL-1β, IL-6, IFN-γ, and TNF-α were returned to the normal levels in pneumonic lambs treated with the combination therapy. The obtained results indicate the selective influences of vitamin C on pro-inflammatory cytokines production in sera of lambs with pneumonic pasteurellosis and highlights the value of vitamin C as a potential anti-inflammatory drug and ideal immunomodulatory agent.
- Published
- 2021
27. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
- Author
-
Mohamed Abdo, Rizk, Shimaa Abd El-Salam, El-Sayed, Mahmoud S, Alkhoudary, Khalaf F, Alsharif, Mohamed M, Abdel-Daim, and Ikuo, Igarashi
- Subjects
Imidocarb ,large-scale screening ,Plants, Medicinal ,Antiprotozoal Agents ,Babesia ,in vitro ,Article ,Malaria ,Babesia divergens ,MMV006913 ,Babesiosis ,malaria box ,Blood-Borne Pathogens ,Animals ,Humans ,Diminazene ,Atovaquone - Abstract
Babesiosis is an infectious disease with an empty drug pipeline. A search inside chemical libraries for novel potent antibabesial candidates may help fill such an empty drug pipeline. A total of 400 compounds (200 drug-like and 200 probe-like) from the Malaria Box were evaluated in the current study against the in vitro growth of Babesia divergens (B. divergens), a parasite of veterinary and zoonotic importance. Novel and more effective anti-B. divergens drugs than the traditionally used ones were identified. Seven compounds (four drug-like and three probe-like) revealed a highly inhibitory effect against the in vitro growth of B. divergens, with IC50s ≤ 10 nanomolar. Among these hits, MMV006913 exhibited an IC50 value of 1 nM IC50 and the highest selectivity index of 32,000. The atom pair fingerprint (APfp) analysis revealed that MMV006913 and MMV019124 showed maximum structural similarity (MSS) with atovaquone and diminazene aceturate (DA), and with DA and imidocarb dipropionate (ID), respectively. MMV665807 and MMV665850 showed MMS with each other and with ID. Of note, a high concentration (0.75 IC50) of MMV006913 caused additive inhibition of B. divergens growth when combined with DA at 0.75 or 0.50 IC50. The Medicines for Malaria Venture box is a treasure trove of anti-B. divergens candidates according to the obtained results.
- Published
- 2021
28. Effects of Methanolic Extract from Turmeric (Curcuma longa) against the In Vitro Multiplication of Several Babesia Species and Theileria equi
- Author
-
Ikuo Igarashi, Mohamed Abdo Rizk, and Shimaa Abd El-Salam El-Sayed
- Subjects
biology ,Traditional medicine ,turmeric ,Babesiosis ,in vitro ,medicine.disease ,biology.organism_classification ,In vitro ,combination therapy ,Curcuma longa ,Theileria ,Toxicity ,Babesia ,medicine ,Parasite hosting ,Babesia species ,Curcuma - Abstract
Anti-piroplasm drugs currently on the market have proven toxicity to the host and parasite resistance. Plants are possible sources of novel drugs. Subsequently, a novel strategy should be used to find new anti-piroplasm agents that are both effective and safe. In the present study, we have evaluated the effect of turmeric (Curcuma longa) methanolic extract on the in vitro growth of Babesia (B.) bovis, B. divergens, B. caballi, and Theileria (T.) equi. The in vitro inhibitory effectiveness of turmeric was assessed using a fluorescence test. The enhancement in the in vitro inhibitory efficacy of turmeric when administrated in combination with diminazene aceturate (DA) was investigated using in vitro cultures of different piroplasm parasites. Turmeric reduced the in vitro growth of B. bovis, B. divergens, T. equi, and B. caballi with IC50 values of 0.830 ± 0.078, 0.375 ± 0.055, 1.405 ± 0.575, and 0.720 ± 0.090 mg/mL, respectively. An amount of 1 mg/mL turmeric for B. bovis, 0.5 mg/mL turmeric for B. divergens, 1 mg/mL turmeric for T. equi, and 0.5 mg/mL turmeric for B. caballi exhibited 73.43%, 80.065%, 73.47%, and 47.375% inhibitions in the growth of the parasites, respectively. When turmeric was combined with DA, its in vitro inhibitory impact on bovine Babesia and equine Babesia/Theileria parasites was amplified. These findings show that a methanolic extract of turmeric could be a promising medicinal plant for the treatment of babesiosis, especially when administered in conjunction with DA.
- Published
- 2021
- Full Text
- View/download PDF
29. Abdominal Hernia in Equine: Animal Level Risk Factors and Repair Using Polypropylene Mesh
- Author
-
Alaa Moustafa, Mohammed Elmetwally, Sabry EL-Khodery, Mohamed Hamed, Naglaa Gomaa, and Mohamed Abdo Rizk
- Subjects
Male ,Equine ,Recurrence ,Risk Factors ,Animals ,Female ,Horse Diseases ,Equidae ,Horses ,Surgical Mesh ,Polypropylenes ,Hernia, Ventral - Abstract
There is a paucity of information regarding the frequency and risk factors associated with the occurrence of an abdominal hernia in different equine species especially donkeys, and mules. In addition, the effectiveness of using polypropylene mesh for the surgical management of abdominal hernia in donkeys and mules is still unknown. The purpose of the present study was to evaluate the efficacy of using polypropylene mesh for the surgical treatment of abdominal hernia in horses, donkeys, and mules and to address the occurrence and risk factors associated with an abdominal hernia in the selected animal species. Based on clinical and ultrasound proof of abdominal hernia, 48 animals were included in the current study. A questionnaire was created to imply the assumed risk factors associated with occurence and clinical findings of abdominal hernia. Hernioplasty using polypropylene mesh was used for the surgical treatment. The abdominal hernia was prevalent (P.05) in foals followed by adult horses, donkeys, and mules (25, 15, 6, and 2), respectively. Ages from 3 to 5 years exhibited more abdominal hernias in donkeys, mules, and horses (12.5%, 4.2%, and 31.3%, P.05), respectively. In all studied animals, females were more prevalent than males (70.8%, n = 34 vs. 29.2%, n = 14) respectively. The complication of abdominal wall hernia was positively affected by the time to repair admitted cases (P = .000). The majority of the animals (36 cases) recovered without complications, however, 10 cases had mild difficulties such as suture abscess, wound infection, serous fluid accumulation, and hematoma postsurgery. In addition, two cases of postoperative recurrence were documented. The results herein indicated that polypropylene mesh hernioplasty may be an alternative to the treatment of equine abdominal hernia. Recognizing the potential risk factors associated with an abdominal hernia in different equine species may be helpful to construct the best preventive measures.
- Published
- 2021
30. MMV020275 and MMV020490, promising compounds from malaria box for the treatment of equine piroplasmosis
- Author
-
Mohamed Abdo Rizk, Shimaa Abd El-Salam El-Sayed, Rasha Eltaysh, and Ikuo Igarashi
- Subjects
Babesia ,Real-Time Polymerase Chain Reaction ,Microbiology ,Malaria ,Theileriasis ,Mice ,Infectious Diseases ,Insect Science ,Babesiosis ,Theileria ,Animals ,Parasitology ,Cattle ,Horse Diseases ,Horses - Abstract
Equine piroplasmosis is a tick-transmitted disease that is considered one of the most serious infectious diseases affecting equines. Searching for novel antipiroplasm drugs remains indispensable due to the emergence and spreading of resistant piroplasm parasites against the limited currently used drugs, diminazene aceturate and imidocarb dipropionate. Therefore, novel drugs with specified targets need to be identified and exploited. The inhibitory effects of Medicines for Malaria Venture (MMV) Malaria Box compounds with potent in vitro anti-equine piroplasmosis activity were evaluated against the growth of B. microti in mice in this study. Using a nested PCR assay targeting the B. microti ss-rRNA gene, we investigated the far-reaching impacts of effective combinations to inhibit parasite recrudescence. Using real-time PCR, this study revealed potential targets for the found potent compounds. When used as monotherapy, screening the Malaria Box against the in vivo growth of the B. microti parasite resulted in the discovery of new, potent antipiroplasm medicines, such as MMV020275 and MMV020490. In MMV020275-treated Theileria equi in vitro culture, a statistically significant difference (P0.05) in the cGMP-dependent protein kinase (PKG) mRNA level was identified as a down-regulation in contrast to non-treated cultures. In conclusion, new potent antipiroplasm drugs, including MMV020275 and MMV020490 are identified. MMV020275 significantly down-regulate the mRNA levels of the PKG gene. Clofazimine enhanced the inhibitory efficacy of MMV compounds which is suggested to use in treatment of animal or human babesiosis in the future.
- Published
- 2021
31. Effect of methanolic extract from
- Author
-
Mohamed Abdo, Rizk, Shimaa Abd, El-Salam El-Sayed, Mostafa, Al-Araby, and Ikuo, Igarashi
- Abstract
Piroplasmosis is a serious disease that infects animals, inflicting significant economic losses in the livestock industry and animal trade worldwide. Anti-piroplasm drugs now on the market have demonstrated host toxicity and parasite resistance. As a result, developing more effective and safer anti-piroplasm drugs becomes an urgent issue. This study aimed to evaluate the inhibitory effect ofFluorescence-based SYBR Green I assay was used to evaluate CA's inhibitory effectTheThe obtained results indicate that CA might be a promising medicinal plant for treating babesiosis, especially when used with a low dose of DA.
- Published
- 2021
32. Molecular Epidemiology and Species Diversity of Tick-Borne Pathogens of Animals in Egypt: A Systematic Review and Meta-Analysis
- Author
-
El-Sayed El-Alfy, Ibrahim Abbas, Hanadi B. Baghdadi, Shimaa Abd El-Salam El-Sayed, Shengwei Ji, and Mohamed Abdo Rizk
- Subjects
Microbiology (medical) ,Infectious Diseases ,General Immunology and Microbiology ,Immunology and Allergy ,Molecular Biology - Abstract
Ticks and tick-borne pathogens (TTBPs) are listed among the most serious concerns harming Egyptian livestock’s productivity. Several reports on tick-borne pathogens (TBPs) from various geographical regions in the country were published. However, data on the molecular characterization of TBPs are the most beneficial for understanding the epidemiology of this important group of pathogens. In this study, we present the first meta-analysis on the molecular epidemiology and species diversity of TBPs infecting animals in Egypt. All published studies on TBPs were systematically collected from various databases (PubMed, Scopus, ScienceDirect, the Egyptian Knowledge Bank, and Google Scholar). Data from eligible papers were extracted and subjected to various analyses. Seventy-eight studies were found to be eligible for inclusion. Furthermore, ticks infesting animals that were molecularly screened for their associated pathogens were also included in this study to display high species diversity and underline the high infection risk to animals. Theileria annulata was used as parasite model of TBPs to study the genetic diversity and transmission dynamics across different governorates of Egypt. This study extends cross-comparisons between all published molecular data on TBPs in Egypt and provides resources from Egyptian data in order to better understand parasite epidemiology, species diversity, and disease outcome as well as the development and implementation of prevention and control methods for public health, veterinary care practitioners, and animal owners all over the country.
- Published
- 2022
33. Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites
- Author
-
Mohamed Abdo Rizk, Dickson Stuart Tayebwa, Azirwan Guswanto, Naoaki Yokoyama, Bumduuren Tuvshintulga, Ikuo Igarashi, Sambuu Gantuya, Amany Magdy Beshbishy, Gaber El-Saber Batiha, T Sivakumar, and Arifin Budiman Nugraha
- Subjects
0301 basic medicine ,Male ,Erythrocytes ,ved/biology.organism_classification_rank.species ,Drug Evaluation, Preclinical ,chemistry.chemical_compound ,Diminazene ,Mice ,0302 clinical medicine ,Theileria ,Pharmacology (medical) ,Pathogen ,Babesia bigemina ,Mice, Inbred BALB C ,biology ,Drug Synergism ,Infectious Diseases ,Drug screening ,Imidocarb ,Toxicity ,Drug Therapy, Combination ,Female ,medicine.drug ,Babesia caballi ,030231 tropical medicine ,Babesia ,Article ,Microbiology ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Inhibitory Concentration 50 ,Babesiosis ,parasitic diseases ,medicine ,Pathogen Box ,Animals ,Humans ,lcsh:RC109-216 ,IC50 ,Pharmacology ,ved/biology ,Babesia bovis ,Antipruritics ,biology.organism_classification ,Theileriasis ,030104 developmental biology ,chemistry ,Parasitology ,Cattle ,Antipiroplasm agent - Abstract
Diminazene aceturate (DA) and imidocarb dipropionate are commonly used in livestock as antipiroplasm agents. However, toxic side effects are common in animals treated with these two drugs. Therefore, evaluations of novel therapeutic agents with high efficacy against piroplasm parasites and low toxicity to host animals are of paramount importance. In this study, the 400 compounds in the Pathogen Box provided by the Medicines for Malaria Venture foundation were screened against Babesia bovis, Babesia bigemina, Babesia caballi, and Theileria equi. A fluorescence-based method using SYBR Green 1 stain was used for initial in vitro screening and determination of the half maximal inhibitory concentration (IC50). The initial in vitro screening performed using a 1 μM concentration as baseline revealed nine effective compounds against four tested parasites. Two “hit” compounds, namely MMV021057 and MMV675968, that showed IC50 100 were selected. The IC50s of MMV021057 and MMV675968 against B. bovis, B. bigemina, T. equi and B. caballi were 23, 39, 229, and 146 nM, and 2.9, 3, 25.7, and 2.9 nM, respectively. In addition, a combination of MMV021057 and DA showed additive or synergistic effects against four tested parasites, while combinations of MMV021057 with MMV675968 and of MMV675968 with DA showed antagonistic effects. In mice, treated with 50 mg/kg MMV021057 and 25 mg/kg MMV675968 inhibited the growth of Babesia microti by 54 and 64%, respectively, as compared to the untreated group on day 8. Interestingly, a combination treatment with 6.25 mg/kg DA and 25 mg/kg MMV021057 inhibited B. microti by 91.6%, which was a stronger inhibition than that by single treatments with 50 mg/kg MMV021057 and 25 mg/kg DA, which showed 54 and 83% inhibition, respectively. Our findings indicated that MMV021057, MMV675968, and the combination treatment with MMV021057 and DA are prospects for further development of antipiroplasm drugs., Graphical abstract Image 1, Highlights • Nine of 400 MMV compounds suppressed the in vitro growth of piroplasm parasites. • MMV021057 and MMV675968 showed effects similar to those of DA. • Combinations of MMV021057 and DA had additive or synergistic effects on parasites. • MMV021057 and MMV675968 moderately inhibited the growth of B. microti in mice. • A combination treatment with MMV021057 and DA highly inhibited B. microti in mice.
- Published
- 2019
34. Antimicrobial resistance profiles and virulence genotyping of Salmonella enterica serovars recovered from broiler chickens and chicken carcasses in Egypt
- Author
-
Amira I. Zakaria, Shimaa Abd El-Salam El-Sayed, Mona Elsayed, Mohamed Abdo Rizk, and Rasha M. Elkenany
- Subjects
Imipenem ,Salmonella ,Meat ,Genotype ,040301 veterinary sciences ,Virulence ,Drug resistance ,medicine.disease_cause ,Microbiology ,0403 veterinary science ,03 medical and health sciences ,Antibiotic resistance ,Drug Resistance, Bacterial ,medicine ,Animals ,Food microbiology ,030304 developmental biology ,Salmonella Infections, Animal ,0303 health sciences ,lcsh:Veterinary medicine ,General Veterinary ,biology ,Salmonella enterica ,04 agricultural and veterinary sciences ,General Medicine ,biology.organism_classification ,Housing, Animal ,Anti-Bacterial Agents ,Multiple drug resistance ,Food Microbiology ,lcsh:SF600-1100 ,Egypt ,Chickens ,Research Article ,medicine.drug - Abstract
Background This study aimed to survey the prevalence, antimicrobial resistance, and virulence-associated genes of Salmonella enterica recovered from broiler chickens and retail shops at El-Sharkia Province in Egypt. Salmonella virulence factors were determined using the polymerase chain reaction assays targeting the invA, csgD, hilC, bcfC, stn, avrA, mgtC, ompF, sopE1 and pefA genes. Results One hundred tweenty out of 420- samples from broiler chickens’ cloacal swabs, farm environmental samples, and freshly dressed whole chicken carcasses were positive Salmonella species. The isolates were serotyped as S. Enteritidis as the most dominant serotypes. Interestingly, none of the isolates were resistant to imipenem. The multidrug resistance was determined in 76.7% of the isolates with multidrug antibiotic resistance index of 0.2–0.6. Eight virulence genes (invA, csgD, hilC, stn, bcfC, mgtC, avrA, and ompf) were characterized among 120 S. enterica isolates with variable frequencies, while sopE1and pefA genes that were completely absent in all isolates. Based on the combination of presence and absence of virulence genes, the most common genetic profile (P7, 30%) was invA and csgD genes. Conclusion S. Enteritidis and S. Typhimurium were the most common identified serotypes in the examined sources. Circulation of such strains in broiler farms required introducing special biosecurity and biocontrol measures for control of Salmonella. Such measures might limit the adverse effects of antibiotics and ensure the safety of the environment and animal-derived food. Electronic supplementary material The online version of this article (10.1186/s12917-019-1867-z) contains supplementary material, which is available to authorized users.
- Published
- 2019
35. Dietary flaxseed oil inhibits kidney NF-kappa B activation and pro-inflammatory cytokine expression in cisplatin-treated rats
- Author
-
Hend Samy Kheira, Shimaa Abd El-Salam El-Sayed, Gehad El-Sayed, and Mohamed Abdo Rizk
- Subjects
Cisplatin ,Kidney ,medicine.medical_specialty ,Antioxidant ,Combination therapy ,040301 veterinary sciences ,business.industry ,medicine.medical_treatment ,Renal function ,Interleukin ,04 agricultural and veterinary sciences ,Pathology and Forensic Medicine ,0403 veterinary science ,medicine.anatomical_structure ,Endocrinology ,Downregulation and upregulation ,Internal medicine ,medicine ,Tumor necrosis factor alpha ,Anatomy ,business ,medicine.drug - Abstract
The current study explores the anti-inflammatory effect of flaxseed oil (FXO) on cisplatin (CP)-induced renal damage. Rats prefed with normal experimental diets (normal/FXO diet) for 10 days were administered 30 mg kg−1 and 50 mg kg−1 i.p. CP in a single dose, while still on the experimental diets. Significant improvement in kidney function test and antioxidant enzyme activities in rats treated with combination therapy (FXO + CP) was detected. Interestingly, treatment by FXO resulted in significant downregulation (P < 0.05) in interleukin (IL)-6 and IL-1β expression in the renal tissue in comparison with CP-treated rats. Moreover, administration of FXO yielding negative and mild positive brown immunostain for tumor necrosis factor-alpha (TNF-α) or mild and moderate positive brown immunostain for nuclear factor Kappa B (NF-kB) in the renal tissue of rats treated with 3 mg kg−1 CP + FXO and 5 mg kg−1 CP + FXO, respectively. The obtained results highlight the ameliorative anti-inflammatory effect of FXO in the renal damage associated with CP administration and confirm the necessity and usefulness of FXO dietary supplement when using CP in the treatment of cancer patients.
- Published
- 2018
36. An epidemiological survey of bovine viral diarrhea infection in calves in Egypt with identification of high prevalence of persistent infected animals
- Author
-
Samar Atwa, Mohamed El-Beskawy, Sayed M. Zeidan, Younis E. Emad, and Mohamed Abdo Rizk
- Subjects
medicine.medical_specialty ,High prevalence ,Hematology ,040301 veterinary sciences ,business.industry ,04 agricultural and veterinary sciences ,Virology ,Virus ,Pathology and Forensic Medicine ,0403 veterinary science ,Reverse transcription polymerase chain reaction ,Vaccination ,Internal medicine ,Epidemiology ,medicine ,Serum neutralization test ,Anatomy ,Viral diarrhea ,business - Abstract
In the present study, we identified the persistent infection by bovine viral diarrhea virus (BVDV) in 45 clinically suspected persistent infected (PI) calves and 260 apparently healthy calves from Damietta governorate (North) in Egypt during 2016 using enzyme-linked immunosorbent assay (ELISA), serum neutralization test (SNT), immunohistochemistry (IHC), and reverse transcription polymerase chain reaction (RT-PCR). The identification of PI calves was performed after vaccination by CattleMaster® 4. The age of PI calves in the current study was ranged from 2 to 4 months (n = 7) and from 5 to 8 months (n = 38). ELISA revealed the infection in 4 clinically suspected PI calves (57.14%) aged 2 to 4 months. While the infection did not approve in any of the calves within this age using RT-PCR, for calves aged from 5 to 8 months old, ELISA showed the infection in 30 calves (78.94%), and from these calves, the infection was confirmed in 6 calves (15.79%) only using RT-PCR. For apparently clinically healthy animals, 11 transiently infected calves were identified by IHC (positive), SNT (positive), and RT-PCR (negative) at 2 months’ post-vaccination. Collectively, the persistent infection was confirmed in 9 calves (2.95%) out of 305 calves. In summary, our study detected a high prevalence of PI calves with BVDV in Damietta province in Egypt, which highlights the importance of introducing effective prevention and control strategies throughout Egypt to minimize the prevalence of BVDV.
- Published
- 2018
37. PLK:Δgra9 Live Attenuated Strain Induces Protective Immunity Against Acute and Chronic Toxoplasmosis
- Author
-
Jixu Li, Eloiza May Galon, Huanping Guo, Mingming Liu, Yongchang Li, Shengwei Ji, Iqra Zafar, Yang Gao, Weiqing Zheng, Paul Franck Adjou Moumouni, Mohamed Abdo Rizk, Maria Agnes Tumwebaze, Byamukama Benedicto, Aaron Edmond Ringo, Tatsunori Masatani, and Xuenan Xuan
- Subjects
Microbiology (medical) ,lcsh:QR1-502 ,Toxoplasma gondii ,Microbiology ,Immunoglobulin G ,lcsh:Microbiology ,03 medical and health sciences ,protective immunity ,Immune system ,medicine ,PLK:Δgra9 ,030304 developmental biology ,Original Research ,0303 health sciences ,live attenuated vaccine ,Attenuated vaccine ,biology ,030306 microbiology ,Immunogenicity ,biology.organism_classification ,medicine.disease ,Virology ,Toxoplasmosis ,Vaccination ,Humoral immunity ,biology.protein ,toxoplasmosis - Abstract
Toxoplasmosis is a zoonotic parasitic disease caused by the obligate intracellular protozoa Toxoplasma gondii, which threatens a range of warm-blooded mammals including humans. To date, it remains a challenge to find safe and effective drug treatment or vaccine against toxoplasmosis. In this study, our results found that the development of a mutant strain based on gene disruption of dense granule protein 9 (gra9) in type II PLK strain decreased parasite replication in vivo, severely attenuated virulence in mice, and significantly reduced the formation of cysts in animals. Hence, we developed an immunization scheme to evaluate the protective immunity of the attenuated strain of Δgra9 in type II PLK parasite as a live attenuated vaccine against toxoplasmosis in the mouse model. Δgra9 vaccination-induced full immune responses characterized by significantly high levels of pro-inflammatory cytokine interferon gamma (IFN-γ) and interleukin-12 (IL-12), maintained the high T. gondii-specific immunoglobulin G (IgG) level, and mixed high IgG1/IgG2a levels. Their levels provided the complete protective immunity which is a combination of cellular and humoral immunity in mouse models against further infections of lethal doses of type I RH, type II PLK wild-type tachyzoites, or type II PLK cysts. Results showed that Δgra9 vaccination proved its immunogenicity and potency conferring 100% protection against acute and chronic T. gondii challenges. Together, Δgra9 vaccination provided safe and efficient immune protection against challenging parasites, suggesting that PLK:Δgra9 is a potentially promising live attenuated vaccine candidate.
- Published
- 2021
38. Molecular Detection and Identification of Babesia spp., and Trypanosoma spp. in One-humped Camel (Camelus dromedarius) in Halayeb and Shalateen, Egypt
- Author
-
Mohamed Abdo Rizk, Mohamed El-Adl, Shimaa Abd El-Salam El-Sayed, Mostafa AbdElsalam Alaraby, Mohamed El-Beskawy, Mosaab A. Omar, Magdy Elgioushy, Shimaa Sobhy Sorour, Mohammad I. Al-Wabel, and Mayar Ali
- Subjects
animal diseases ,Babesia ,parasitic diseases ,Trypanosoma ,biochemistry ,Identification (biology) ,Biology ,biology.organism_classification ,Microbiology - Abstract
Phylogenetic analysis of blood parasite infections including Babesia (B.) bovis, Babesia microti and Trypanosoma (T.) spp. in one-humped camel (Camelus dromedarius) (n= 142) breeds in Halayeb and Shalateen, in Upper Egypt were performed in the current study. Polymerase chain reaction (PCR) assays targeting the Rhoptry Associated Protein-1 (RAP-1), Babesia microti small subunit rRNA (ss-rRNA) and internal transcribed spacer 1 (ITS1) genes were used to detect the prevalence of B. bovis, B. microti and Trypanosoma spp. in camels, respectively. Nested PCR assays were used for the detection of Babesia spp. (B. bovis and B. microti). While, KIN-multi species PCR reaction was employed to detect and identify trypanosome DNA in camels. B. microti was detected in (17/142) with infection rate (11.97 %). Sequencing and phylogenetic analyses revealed that B. microti detected in camel was closely related to the German strain in rats and voles in France. B. bovis was also detected in (4/142) with infection rate (2.81%). The sequence and phylogenetic analyses revealed that the isolated B. bovis was closely related to strains isolated from Argentine, USA and Brazil. Moreover, T. evansi was detected in (8/142) with infection rate (5.63%). Sequence and phylogenetic analyses revealed that isolated T. evansi was closely related to T. theileri that was detected from cattle in Brazil. This study provides the first evidence of B. microti in camel in Egypt and highlights the possible role of one-humped camels in maintaining the enzootic cycle of Babesia transmission in Egypt.
- Published
- 2020
39. Molecular Detection and Identification of Babesia spp., Theileria spp., and Anaplasma spp. in Sheep From Border Regions, Northwestern China
- Author
-
Xuenan Xuan, Qingyong Guo, Eloiza May Galon, Shengwei Ji, Jixu Li, Bayin Chahan, Yongchang Li, Mingming Liu, Paul Franck Adjou Moumouni, and Mohamed Abdo Rizk
- Subjects
Veterinary medicine ,sheep ,China ,Anaplasma ,040301 veterinary sciences ,Babesia ,18S ribosomal RNA ,0403 veterinary science ,03 medical and health sciences ,Theileria ,parasitic diseases ,medicine ,Ovis ,030304 developmental biology ,0303 health sciences ,lcsh:Veterinary medicine ,General Veterinary ,biology ,04 agricultural and veterinary sciences ,biology.organism_classification ,16S ribosomal RNA ,medicine.disease ,Coinfection ,lcsh:SF600-1100 ,Nested polymerase chain reaction - Abstract
Babesia, Theileria, and Anaplasma are important causative agents of tick-borne diseases that severely affect sheep. However, there is paucity in the occurrence genetic diversity of the infections of tick-borne diseases in sheep in border regions, northwestern China. In this study, nested polymerase chain reaction (nPCR) assays and gene sequencing were used to identify tick-borne Babesia spp., Theileria spp., and Anaplasma spp. infections in border regions, northwestern China. Out of 323 samples tested in this study, 225 (69.7%) sheep were infected with Babesia spp., Theileria spp., and Anaplasma spp. Two hundred six (63.8%), 60 (18.6%), 54 (16.7%), 51 (15.8%), 32 (9.9%), 19 (5.9%), and 16 (5.0%) were positive for A. ovis, B. motasi-like, A. bovis, T. uilenbergi, A. phagocytophilum, T. luwenshuni, and B. motasi-like Xinjiang, respectively. The most common dual infection was with A. ovis and B. motasi-like while the most frequent triple coinfection was A. ovis, B. motasi-like, and T. uilenbergi with coinfection rates of 17.0% (55/323) and 5.0% (16/323), respectively. Sequencing analysis indicated that A. ovis MSP4, A. phagocytophilum epank1, A. bovis 16S rRNA, B. motasi-like rap1-b, B. motasi-like Xinjiang rap1-a, T. luwenshuni 18S rRNA, and T. uilenbergi 18S rRNA from border regions, northwestern China, showed 99-100% identity with documented isolates from other countries. To the best of the authors' knowledge, this is the first report of T. uilenbergi and T. luwenshuni infections of sheep in border regions, northwestern China. Furthermore, these findings provide important data for understanding the distribution of Babesia, Theileria, and Anaplasma in sheep between border countries and China.
- Published
- 2020
40. Impact of using pyronaridine tetraphosphate- based combination therapy in the treatment of babesiosis caused by Babesia bovis, B. caballi, and B. gibsoni in vitro and B. microti in mice
- Author
-
Yongchang Li, Ikuo Igarashi, Aaron Edmond Ringo, Xuenan Xuan, Maria Agnes Tumwebaze, Mingming Liu, Benedicto Byamukama, Shengwei Ji, Jixu Li, Mohamed Abdo Rizk, and Shimaa Abd El-Salam El-Sayed
- Subjects
0301 basic medicine ,Combination therapy ,030231 tropical medicine ,Antiprotozoal Agents ,Babesia ,Microbiology ,Clofazimine ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Babesiosis ,medicine ,Pyronaridine tetraphosphate ,Animals ,Naphthyridines ,Mice, Inbred BALB C ,biology ,Chemistry ,fungi ,Babesia bovis ,030108 mycology & parasitology ,medicine.disease ,biology.organism_classification ,In vitro ,Disease Models, Animal ,Infectious Diseases ,Parasitology ,Female ,ANTIBABESIAL DRUGS ,medicine.drug - Abstract
The inhibitory efficacies of pyronaridine tetraphosphate (PYR), when used in combination with two novel and potent antibabesial drugs; clofazimine (CF), and MMV396693 were evaluated in the current study against the growth of Babesia bovis, B. caballi, and B. gibsoni in vitro and B. microti in mice. The in vitro study against the selected parasites was performed using combination of PYR with either CF or MMV396693 in ratios ranged from 0.75:0.75 to 0.25:0.25. Combined application of PYR/MMV396693 revealed additive and indifferent interactions against the in vitro growth of all screened Babesia parasites. PYR in combination with CF, achieved indifferent and antagonistic interactions with all used concentration ratios against the in vitro growth of B. bovis and B. caballi. Treatment with PYR-CF combination therapy caused significant inhibition (P 0.05) of the fluorescence values at days 12, 14, 16, 18, and 22 p.i. in comparison with control mice. Of note, treatment with combination therapy exhibited inhibition in the growth of B. microti (23.16%) greater than those caused by PYR alone. In summary, the obtained results highlight the improvement in the in vivo antibabesial efficacy of PYR when used in combination with CF rather than using PYR alone but such inhibition is still lower than those caused by either DA or CF monotherapies.
- Published
- 2020
41. First detection of Anaplasma ovis in sheep and Anaplasma platys-like variants from cattle in Menoufia governorate, Egypt
- Author
-
Maria Agnes Tumwebaze, Hany M. Ibrahim, Benedicto Byamukama, Asmaa Galal-Khallaf, Yongchang Li, Shengwei Ji, Jixu Li, Heba M. Abd El latif, Mingming Liu, Aaron Edmond Ringo, Sherin K. Sheir, Hiroshi Suzuki, Khaled Mohammed-Geba, Paul Franck Adjou Moumouni, Mohamed Abdo Rizk, Nora M. Bishr, Dalia S Morsi, Xuenan Xuan, Eloiza May Galon, and Seung-Hun Lee
- Subjects
Anaplasma platys ,Male ,Veterinary medicine ,Anaplasmosis ,Anaplasma ,Buffaloes ,animal diseases ,Cattle Diseases ,Biology ,parasitic diseases ,Animals ,Ovis ,Disease treatment ,Ehrlichia ,business.industry ,Anaplasma ovis ,Incidence ,biology.organism_classification ,Infectious Diseases ,Parasitology ,Livestock ,Cattle ,Egypt ,Female ,Babesia species ,business - Abstract
Tick-borne diseases are of global economic importance, especially due to the costs associated with disease treatment and productivity losses in livestock. In this study, 244 livestock animals (cattle N = 92, buffaloes N = 86 and sheep N = 66) from Menoufia, Egypt were tested for Anaplasma, Ehrlichia and Babesia species using PCR. Results revealed detection of A. ovis (9.1%) in sheep while Anaplasma spp. (14.1%), A. marginale (15.2%), B. bigemina (6.5%) and B. bovis (5.4%) in cattle. On the other hand, Anaplasma spp. (1.2%), A. marginale (1.2%) and B. bovis (1.2%), were detected in buffaloes. Significantly higher detection rates were observed in cattle for Anaplasma spp. (P = .020), A. marginale (P = .001) and B. bigemina (P = .022) than in buffaloes. Sequence analysis of Anaplasma spp. isolates from cattle, revealed A. platys-like strains. Phylogenetic analyses of the A. platys-like isolates revealed variation among the strains infecting cattle. The A. marginale buffalo isolate, on the other hand, showed some level of divergence from the cattle isolates. This study reports the first detection of A. ovis in sheep and A. platys-like strains in cattle in Menoufia and Egypt at large. The results of the current study provide valuable information on the epidemiology and genetic characteristics of tick-borne pathogens infecting livestock in Egypt.
- Published
- 2020
42. Molecular Detection and Identification of
- Author
-
Yongchang, Li, Eloiza May, Galon, Qingyong, Guo, Mohamed Abdo, Rizk, Paul Franck Adjou, Moumouni, Mingming, Liu, Jixu, Li, Shengwei, Ji, Bayin, Chahan, and Xuenan, Xuan
- Subjects
sheep ,China ,Anaplasma ,Theileria ,parasitic diseases ,Babesia ,Veterinary Science ,Brief Research Report - Abstract
Babesia, Theileria, and Anaplasma are important causative agents of tick-borne diseases that severely affect sheep. However, there is paucity in the occurrence genetic diversity of the infections of tick-borne diseases in sheep in border regions, northwestern China. In this study, nested polymerase chain reaction (nPCR) assays and gene sequencing were used to identify tick-borne Babesia spp., Theileria spp., and Anaplasma spp. infections in border regions, northwestern China. Out of 323 samples tested in this study, 225 (69.7%) sheep were infected with Babesia spp., Theileria spp., and Anaplasma spp. Two hundred six (63.8%), 60 (18.6%), 54 (16.7%), 51 (15.8%), 32 (9.9%), 19 (5.9%), and 16 (5.0%) were positive for A. ovis, B. motasi-like, A. bovis, T. uilenbergi, A. phagocytophilum, T. luwenshuni, and B. motasi-like Xinjiang, respectively. The most common dual infection was with A. ovis and B. motasi-like while the most frequent triple coinfection was A. ovis, B. motasi-like, and T. uilenbergi with coinfection rates of 17.0% (55/323) and 5.0% (16/323), respectively. Sequencing analysis indicated that A. ovis MSP4, A. phagocytophilum epank1, A. bovis 16S rRNA, B. motasi-like rap1-b, B. motasi-like Xinjiang rap1-a, T. luwenshuni 18S rRNA, and T. uilenbergi 18S rRNA from border regions, northwestern China, showed 99–100% identity with documented isolates from other countries. To the best of the authors' knowledge, this is the first report of T. uilenbergi and T. luwenshuni infections of sheep in border regions, northwestern China. Furthermore, these findings provide important data for understanding the distribution of Babesia, Theileria, and Anaplasma in sheep between border countries and China.
- Published
- 2020
43. Myrrh Oil in Vitro Inhibitory Growth on Bovine and Equine Piroplasm Parasites and Babesia microti of Mice
- Author
-
Ikuo Igarashi, Shimaa Abd El-Salam El-Sayed, Mahmoud AbouLaila, Mohamed M. Abdel-Daim, Mosaab A. Omar, Amer R. Abdel Aziz, Mohammad Saleh Al-Aboody, and Mohamed Abdo Rizk
- Subjects
Microbiology (medical) ,Myrrh ,animal diseases ,lcsh:Medicine ,Inhibitory postsynaptic potential ,Microbiology ,chemistry.chemical_compound ,In vivo ,parasitic diseases ,Immunology and Allergy ,myrrh oil ,Molecular Biology ,General Immunology and Microbiology ,biology ,lcsh:R ,Babesia bovis ,in vitro ,Ribosomal RNA ,t. equi ,biology.organism_classification ,In vitro ,babesia ,in vivo ,Infectious Diseases ,chemistry ,Babesia ,Luteolin - Abstract
The present experimental study was conducted for the assessment of the efficacy of in vitro inhibition of myrrh oil on the propagation of Babesia bovis, B. divergens, B. bigemina, Theileria equi, and B. caballi and in vivo efficacy on B. microti in mice through fluorescence assay based on SYBR green I. The culture of B. divergens B. bovis and was used to evaluate the in vitro possible interaction between myrrh oil and other commercial compound, such as pyronaridine tetraphosphate (PYR), diminazene aceturate (DA), or luteolin. Nested-polymerase chain reaction protocol using primers of the small-subunit rRNA of B. microti was employed to detect any remnants of DNA for studied parasitic species either in blood or tissues. Results elucidated that, Myrrh oil significantly inhibit the growth at 1% of parasitic blood level for all bovine and equine piroplasm under the study. Parasitic regrowth was inhibited subsequently by viability test at 2 µ, g/mL for B. bigemina and B. bovis, and there was a significant improvement in the in vitro growth inhibition by myrrh oil when combined with DA, PYR, and luteolin. At the same time, mice treated with a combination of myrrh oil/DA showed a higher inhibition in emitted fluorescence signals than the group that challenged with 25 mg/kg of diminazene aceturate at 10 and 12 days post-infection. In conclusion, this study has recommended the myrrh oil to treat animal piroplasmosis, especially in combination with low doses of DA.
- Published
- 2020
44. An epidemiological survey of Theileria equi parasite in donkeys (Equus asinus) in Egypt
- Author
-
Azaa Abdel-Wahab, Ahmed Elkhatam, Mahmoud AbouLaila, Shimaa Abd El-Salam El-Sayed, and Mohamed Abdo Rizk
- Subjects
medicine.medical_specialty ,Veterinary medicine ,General Veterinary ,Pcr cloning ,Acute infection ,Equidae ,Biology ,biology.organism_classification ,Equus asinus ,Equine piroplasmosis ,Polymerase Chain Reaction ,humanities ,Theileriasis ,Theileria equi ,Theileria ,parasitic diseases ,Epidemiology ,medicine ,Parasite hosting ,Animals ,Parasitology ,Egypt ,Donkey - Abstract
In the present study, we conducted an epidemiological survey of Theileria equi, with sequencing analysis of the PCR product using blood–DNA samples collected from donkeys (n = 149) reared in different Egyptian provinces in Lower Egypt (Menoufia and Mersa Matruh) and middle Egypt (Giza). All animals were tested for the presence of T. equi parasite using species-specific PCR assay targeting the Equi merozoite antigen-1 (EMA-1). Nine- (6.04%) samples were positive for T. equi. The highest positive rate for infection was detected in Giza zoological garden (10.16%). Egyptian EMA-1 gene sequence exhibited a high identity with gene sequence from Italy, Japan, South Africa, Indian and Israel, the Palestinian Authority. In conclusion, data presented here revealed for the presence of T. equi in donkeys in two provinces of Egypt either in form of acute infection or carriers. These findings have economic significance and indicate the importance of introducing effective prevention and control strategies throughout Egypt to minimize the prevalence of equine piroplasmosis caused by T. equi.
- Published
- 2020
45. Molecular detection and characterization of tick-borne haemoparasites among cattle on Zanzibar Island, Tanzania
- Author
-
Mingming Liu, Maria Agnes Tumwebaze, Oriel M. M. Thekisoe, Mohamed Abdo Rizk, Aaron Edmond Ringo, Xuenan Xuan, Eloiza May Galon, Benedicto Byamukama, Shengwei Ji, Paul Franck Adjou Moumouni, Yongchang Li, and 26887568 - Thekisoe, Matlahane Molifi Oriel
- Subjects
0301 basic medicine ,Anaplasmosis ,Veterinary medicine ,Anaplasma ,Sequence analysis ,Veterinary (miscellaneous) ,Theileria parva ,030231 tropical medicine ,Population ,Babesia ,Polymerase Chain Reaction ,Tanzania ,18S ribosomal RNA ,law.invention ,03 medical and health sciences ,Ticks ,0302 clinical medicine ,law ,Theileria ,Genotype ,parasitic diseases ,medicine ,Animals ,education ,Phylogeny ,Polymerase chain reaction ,Babesia bigemina ,education.field_of_study ,Tick-borne disease ,biology ,Genetic Variation ,030108 mycology & parasitology ,biology.organism_classification ,medicine.disease ,Theileriasis ,Co-infection ,Infectious Diseases ,PCR ,Tick-Borne Diseases ,Insect Science ,Arachnid Vectors ,Parasitology ,Cattle ,Zanzibar Island - Abstract
Tick-borne diseases (TBDs) are serious constraints to livestock production in Tanzania and other tropical and subtropical countries and impact the livelihoods of resource-poor farming communities in the region. In Tanzania, detailed studies on tick-borne pathogens (TBPs) in cattle using sensitive molecular detection methods are scarce. The objective of this study was to investigate the occurrence and species composition of bovine TBPs in cattle kept in Zanzibar Island. A total of 236 blood samples were randomly collected in cattle population in June and July 2019. We used polymerase chain reaction (PCR) and gene sequencing to detect and identify pathogens. PCR screening of all 236 samples revealed that 64.5% of animals were infected by TBPs, including Theileria parva (34.3%), T. mutans (38.1%), T. taurotragi (30.9%), Anaplasma marginale (10.2%), Babesia bigemina (5.1%), T. velifera (3.4%) and B. bovis (2.1%). Overall a total of 86 animals (36.4%) were co-infected with up to five pathogens including T. parva, T. mutans, T. taurotragi, A. marginale and B. bigemina. The pathogens mostly involved in the co-infection were T. parva, T. taurotragi and T. mutans. Sequence analysis indicated that T. parva p104 and B. bigemina RAP1a genes are diverse among the sampled animals in Zanzibar Island, with 99.64%–100% and 99.51%–100% nucleotide sequence identity value respectively. In contrast, the A. marginale MSP-5, T. mutans 18S rRNA V4 region and B. bovis SBP-2 genes are conserved, with 100%, 99.05%-100% and 99.66%-100% nucleotide sequence identity values respectively. The phylogenetic analyses revealed that T. parva p104 and B. bigemina RAP1a gene sequences showed significant differences of genotypes, as they appear in different clades. Meanwhile, A. marginale MSP-5, T. mutans 18S rRNA V4 region and B. bovis SBP-2 gene sequences appear in the same clade with other sequences extracted from the NCBI GenBank. The epidemiological findings revealed in this study will provide important information on tick-borne diseases in Tanzania and will be used as scientific basis for planning future control strategies.
- Published
- 2020
46. In vivo antibabesial activity and bioinformatic analysis of compounds derived from the Medicines for Malaria Venture box against Babesia microti
- Author
-
Mohamed Abdo Rizk, Shimaa Abd El-Salam El-Sayed, Rasha Eltaysh, and Ikuo Igarashi
- Subjects
Mice ,Babesiosis ,Theileria ,Animals ,Babesia ,Computational Biology ,Cattle ,Parasitology ,Babesia microti ,Molecular Biology ,Malaria - Abstract
Here, we have evaluated the inhibitory effects of Medicines for Malaria Venture (MMV) Malaria Box compounds that exhibited potent in vitro anti-bovine Babesia efficacy against the growth of B. microti in mice and conducted follow-up investigations of the structural similarity between the identified potent MMV compounds and the commonly used antibabesial drugs was performed using atom Pair fingerprints (APfp). Screening the Malaria Box against the in vivo growth of the B. microti parasite helped with the discovery of new, effective anti-bovine Babesia drugs, including MMV667488, MMV007285, and MMV019881. Of note, MMV019881 exhibited the highest anti-B. microti efficacy in vivo among the screened MMV compounds. The APfp results revealed that the maximum structural similarity (MSS) was observed between MMV007285, diminazene aceturate, and imidocarb dipropionate (ID). In the same way, clofazimine (CF) and MMV667488 showed the MSS with either each other based on the analysis. The distance matrix and molecular weight correlation findings highlight the possible potential antibabesial efficacy of MMV667488, ID, and CF when administrated as a combination therapy. In conclusion, in the current study new potent antibabesial drug, MMV019881 was identified. CF and MMV667488 showed the MSS with either each other based on the hierarchical clustering analysis (HCA) and such relation is confirmed by the distance matrix and molecular weight correlation findings. Such combination therapy might have a potential as a novel regime for treating animal or human babesiosis.
- Published
- 2022
47. Farm and animal levels risk factors associated with rectal prolapse in bovine and buffalo calves in Egypt with special reference to the optimal treatment strategy
- Author
-
Alaa, Samy, Eman Abo, Elfadl, Naglaa, Gomaa, Mohamed A, Hamed, Abdelnaser Ahmed, Abdallah, and Mohamed Abdo, Rizk
- Subjects
Farms ,Buffaloes ,General Veterinary ,Risk Factors ,Animals ,Cattle Diseases ,Cattle ,Egypt ,Rectal Prolapse - Abstract
Rectal prolapse (RP) is a serious illness of the rectum and small intestine causing serious health problems in domestic animals. However, there is paucity in the estimation of the risk factors associated with this problem in calves.In the present study, we investigated the prevalence and risk factors associated with the rectal prolapse in both bovine and buffalo calves in Egypt, highlighting the most appropriate treatment strategy.Forty-two calves (23 bovine and 19 buffalo) suffering from varying degrees of rectal prolapse were used. From the owners' anamnesis, the farm- and animal-level risk factors associated with each animal were collected. Fisher's exact tests were used to determine the distribution of frequencies in the different rectal prolapse grades. Descriptive statistics were calculated in the form of mean ± standard deviation (SD) using one-way analysis of variance. Crosstabs were used to determine Spearman's correlation between variables. According to the disease severity, the appropriate treatment strategy was accomplished either by medicinal or surgical interferences.The final logistic regression form demonstrated that the statistical test, Hosmer and Lemeshow's goodness of fit, indicates a significant result (The current study advocates the valid role of resection of rectal mucosa combined with manual reduction and retention in treating calves suffering from grade II rectal prolapse. The final multivariate logistic regression model indicates that the calf's body score is a potential risk factor for the occurrence of RP.
- Published
- 2022
48. Comparative Effect of Intravenous Administration of Medetomidine, Tramadol, and Medetomidine/Tramadol Combination on Intraocular Pressure (IOP) in Clinically Healthy Donkeys (Equus asinus)
- Author
-
Mohamed A. Hamed, Ahmed Hafez, Sabry A. El-Khodery, Mohamed Abdo Rizk, and Abdel Salam El–Mahdi
- Subjects
Intraocular pressure ,Respiratory rate ,040301 veterinary sciences ,Equine ,business.industry ,medicine.medical_treatment ,04 agricultural and veterinary sciences ,Medetomidine ,0403 veterinary science ,03 medical and health sciences ,0302 clinical medicine ,Anesthesia ,Heart rate ,030221 ophthalmology & optometry ,Medicine ,Tramadol Hydrochloride ,Tramadol ,business ,Prospective cohort study ,Saline ,medicine.drug - Abstract
In this study, an analysis of the comparative effect of intravenous medetomidine, tramadol, and medetomidine combined with tramadol on the intraocular pressure in donkeys was conducted. In an experimental randomized prospective study, 24 adult donkeys devoid of ophthalmic defects were allocated randomly into four groups (six each). The first group received medetomidine hydrochloride (MED) intravenously at 0.007 mg kg −1 , and the second group received tramadol hydrochloride (TRA) at 2 mg kg −1 . The third group received a combination of MED and TRA at the same dose rates. However, the fourth group received 10 mL of 0.9% normal saline. Intraocular pressure values, heart rate, respiratory rate, and body temperature were measured before treatment (T0) and at 5, 15, 30, 45, 90, and 120 minutes after treatment. Donkeys treated with MED alone or MED/TRA combination exhibited a significant ( P P
- Published
- 2018
49. Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance
- Author
-
Mahmoud AbouLaila, Naoaki Yokoyama, Ikuo Igarashi, Shimaa Abd El-Salam El-Sayed, Azirwan Guswanto, and Mohamed Abdo Rizk
- Subjects
0301 basic medicine ,Pharmacology ,biology ,medicine.drug_class ,animal diseases ,030106 microbiology ,Antibiotics ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Microbiology ,Trovafloxacin ,03 medical and health sciences ,Infectious Diseases ,parasitic diseases ,Babesia ,medicine ,Enoxacin ,Enrofloxacin ,heterocyclic compounds ,Pharmacology (medical) ,Ofloxacin ,Babesia divergens ,Norfloxacin ,medicine.drug - Abstract
Aim This study aimed to evaluate the inhibitory effects of fluoroquinolone antibiotics, including enrofloxacin, enoxacin, trovafloxacin, norfloxacin, and ofloxacin, on the in vitro and in vivo growth of Babesia divergens and Babesia microti parasites, respectively. Materials and methods The in vitro and in vivo inhibitory effects of fluoroquinolone antibiotics against B. divergens and B. microti, respectively were evaluated using fluorescence-based assay. Additionally, combination therapies of highly effective fluoroquinolone antibiotics (enrofloxacin, enoxacin, and trovafloxacin) with diminazene aceturate, luteolin, or pyronaridine tetraphosphate were tested on the in vitro cultures of B. divergens. Results Enrofloxacin, trovafloxacin, and enoxacin were the most effective fluoroquinolones against the in vitro growth of B. divergens, followed by norfloxacin and ofloxacin. Furthermore, a combination of enoxacin or trovafloxacin with either diminazene aceturate, luteolin, or pyronaridine tetraphosphate significantly enhanced the inhibitory effect on the growth of B. divergens in in vitro cultures. In mice infected by B. microti, enoxacin and diminazene aceturate combination therapy exhibited a potential antibabesial effect. Conclusion These results suggest that safe and cheap fluoroquinolone, such as enoxacin, might be used for the treatment of clinical cases caused by Babesia spp. in animals or humans.
- Published
- 2018
50. Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay
- Author
-
Shimaa Abd El-Salam El-Sayed, Xuenan Xuan, Ikuo Igarashi, Aaron Edmond Ringo, Mohamed Abdo Rizk, Shengwei Ji, Mingming Liu, Benedicto Byamukama, and Yongchang Li
- Subjects
Drug ,High-throughput screening ,media_common.quotation_subject ,Antiprotozoal Agents ,Babesia ,In Vitro Techniques ,Fluorescence ,Molecular biology ,Stain ,In vitro ,High-Throughput Screening Assays ,chemistry.chemical_compound ,Infectious Diseases ,chemistry ,Babesiosis ,Lysis buffer ,SYBR Green I ,Parasitology ,Nerolidol ,media_common - Abstract
In the current study, we evaluated the usefulness of a SYBR Green I (SG I) fluorescence assay for evaluation of the inhibitory effects of antibabesial drugs against the in vitro growth of Babesia gibsoni. Linearity and high-throughput screening (HTS) assays exhibited the validity of the SG I fluorescence assay for B. gibsoni parasite when performed at low hematocrits (HCTs) (2.5% and 5%) without daily changing of the medium. Interestingly, 5% HCT showed the highest value of the signal/noise ratio. Of note, there were no significant differences (P > .05) in the IC50s of the commonly used antibabesial drugs (diminazene aceturate and/or imidocarb dipropionate) that calculated by either the SG I fluorescence assay with and without daily medium changing or by the fluorescence and microscopy methods at 2.5% and 5% HCTs. Such results confirmed that both HCTs are valid for mass drug screening against the in vitro growth of B. gibsoni. While the results of the HTS assay add merit to the assay when performed at 5% HCT especially when incubating the plates for 2 h in a dark after adding lysis buffer with SG I stain. Next, nine different drugs were screened to confirm the assay's usefulness. MMV396693, pyronaridine tetraphosphate and nerolidol drugs exhibited the highest effectiveness against the in vitro growth of B. gibsoni, next to diminazene aceturate. In summary, SG I fluorescence assay with 5% HCT without daily changing of the medium for B. gibsoni offers a novel approach for the large-scale screening of huge chemical libraries in in vitro cultures.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.